Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
September 20, 2024 08:30 ET
|
Fortress Biotech, Inc.
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
September 20, 2024 08:30 ET
|
Alpha Tau Medical Ltd.
JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
September 20, 2024 08:30 ET
|
West Bancorporation
WEST DES MOINES, Iowa, Sept. 20, 2024 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (Nasdaq: WTBA) (the “Company”), parent company of West Bank, will report its results for the third quarter of 2024...
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
September 20, 2024 08:30 ET
|
Autonomix Medical, Inc.
THE WOODLANDS, TX, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...
Rezolve AI to Host Virtual Investor Update on September 26, 2024
September 20, 2024 08:30 ET
|
Rezolve AI Ltd
Rezolve AI aims to become a Leading AI Platform for Commerce in the Global eCommerce Market Rezolve Ai's foundational LLM - brainpowa – Levels-up Conversational Commerce Across 95 Languages Sets out...
M3-Brigade Acquisition V Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 23, 2024
September 20, 2024 08:30 ET
|
M3-Brigade Acquisition V Corp.
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- M3-Brigade Acquisition V Corp. (the “Company”) announced that, commencing on September 23, 2024, holders of the units sold in the Company’s initial...
StoneCo Announces Additional Board Change
September 20, 2024 08:29 ET
|
StoneCo Ltd.
GEORGETOWN, Cayman Islands, Sept. 20, 2024 (GLOBE NEWSWIRE) -- StoneCo Ltd. (Nasdaq: STNE; B3: STOC31) (“Stone” or the “Company”) today announced an additional board change to support the next stage...
Arq, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
September 20, 2024 08:21 ET
|
Arq, Inc.
GREENWOOD VILLAGE, Colo., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Arq, Inc. (NASDAQ: ARQ) (“Arq” or the “Company”), a producer of activated carbon and other environmentally efficient carbon products for...
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron KP.2 angepassten COVID-19-Impfstoff in der Europäischen Union
September 20, 2024 08:10 ET
|
BioNTech SE
Der an Omikron KP.2 angepasste COVID-19-Impfstoff wird nach Zulassung durch die Europäische Kommission für Personen ab 6 Monaten verfügbar seinDaten zeigten, dass der an Omikron KP.2 angepasste...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024 08:10 ET
|
BioNTech SE
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron...